Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

Eli Lilly & Co. (NYSE: LLY) stock was on a tear from 2020 to last year. The question for investors is whether the latest move is more of the recent volatility or a pause before another run higher.

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The ...

We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed. Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top ...

Eli Lilly (LLY) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American stock to currently cross the landmark threshold. The move came as ...

Fintel reports that on November 12, 2025, Citigroup maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy recommendation. Analyst Price Forecast Suggests 8.95% Downside As of November 9, 2025, ...

Nvidia (NVDA) may post sales of $56.8B next week according to Citi. Multiple firms upgraded their price targets ahead of earnings. Sunrun (RUN) was upgraded to buy by Guggenheim with a $27 price ...

Fintel reports that on November 10, 2025, Leerink Partners upgraded their outlook for Eli Lilly and (NYSE:LLY) from Market Perform to Outperform. Analyst Price Forecast Suggests 0.26% Upside As of ...

Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Rising Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) is seen as a strong heal‌thc‌a‍re stock that investors can ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Despite the company's run in recent years, it's not too late to buy. Even with headwinds it has encountered this year, the drugmaker is arguably one of the top stocks in its industry to buy right now.